Effect of Fentanyl on Pain Severity and Duration of Labor

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Nahid Jahani Shoorab, Mashhad University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01648595
First received: July 17, 2012
Last updated: July 23, 2012
Last verified: January 2006

July 17, 2012
July 23, 2012
January 2006
August 2006   (final data collection date for primary outcome measure)
decrease pain and duration of the active phase considerably. [ Time Frame: up to 8 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01648595 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effect of Fentanyl on Pain Severity and Duration of Labor
Principal Investigator

Background: There are two methods of pharmacologic and non- pharmacologic for reducing pain of delivery. It is necessary to be known effect of these drugs on the mother and fetus during labor adverse. Therefore, the purpose of this study was determination of effect of Fentanyl intravenously on pain severity during the active phase of labor.

Not Provided
Interventional
Phase 2
Phase 3
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Decrease Labor Pain
Drug: Fentanyl
In case group, 50 micrograms fentanyl was prescribed in two doses with an interval of 1 hour after being diluted in 4 cc normal saline
  • Experimental: Fentanyl
    In case group, 50 micrograms fentanyl was prescribed in two doses with an interval of 1 hour. In control group was not intervention.
    Intervention: Drug: Fentanyl
  • No Intervention: Without Fentanyl
    The control group did not receive Fentanyl.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
70
September 2006
August 2006   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • multiparas pregnant women (gravid 2-7),
  • term singleton pregnancy,
  • cephalic presentation,
  • low risk pregnancy with no history of drug tolerance (addiction),
  • medical and mental diseases.

Exclusion Criteria:

  • Respiratory rate ≤ 8 or maternal bradycardia (pulse rate less than 60).
Female
21 Years to 37 Years
Not Provided
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT01648595
Effect of Fentanyl
Yes
Nahid Jahani Shoorab, Mashhad University of Medical Sciences
Mashhad University of Medical Sciences
Not Provided
Not Provided
Mashhad University of Medical Sciences
January 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP